Español 
English
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región.
Artículos Relacionados
-
UDIBI
Fecha de publicación: 2 abril de 2020 Development and Evaluation of a Set of Spike and Receptor Binding Domain‐Based...
-
UDIBI
Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine. VER MÁS
-
UDIBI
Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug. VER MÁS
-
UDIBI
Fecha de publicación: 28 de agosto de 2022 Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies Ver más
-
UDIBI
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS
-
-
UDIBI
Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....
-
UDIBI
Fecha de publicación: 10 de abril de 2019 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with...
